چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| ABSTRACT:In the last decade, there has been increasing evidence regarding the anti-proliferative effects of vitamin D. The purpose of present article was to review different aspects of vitamin D on breast cancer. We conducted a comprehensive search in electronic database including PubMed, Medline and Google Scholar for randomized clinical trials published in the last 5 years up to January 2016. A majority of the articles focused on the relationship between vitamin D and risk of breast cancer, and then on the vitaminD's effects on aromatase inhibitors side effects, vitamin D polymorphism and also breast cancer stage. The present literature was unable to prove any association between vitamin D and risk of developing breast cancer; however vitamin D polymorphism is involved in developing breast cancer. On the other hand, high serum level of vitamin D can decrease aromatase inhibitors’musculoskeletaleffects. This can make vitamin D eligible as an adjuvant therapy to cancer treatment.It is highly recommended to treat vitamin D deficiency and provide the ideal serum level of vitamin D among patients with breast cancer who are receiving aromatase inhibitors. |
| نویسنده | نفر چندم مقاله |
|---|---|
| محمد اسمعیل حجازی | دوم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| 87af64c64c18272f971d2671d411da3827ec.pdf | 1398/09/24 | 392929 | دانلود |
